Articles dans des revues avec comité de lecture (103)
  1. 61. El Hajj, P., Gilot, D., Migault, M., Theunis, A., van Kempen, L., Sales, F., Fayyad Kazan, H., Badran, B., Larsimont, D., Awada, A., Bachelot, L., Galibert, M. D., Ghanem, G. E., & Journé, F. (2015). SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma. British Journal of Cancer, 113(1), 91-98. doi:10.1038/bjc.2015.194
  2. 62. Verfaillie, A., Van Den Mooter, L., Claerhout, S., Fiers, M., Journé, F., Ghanem, G. E., Herrmann, C., Halder, G., Marine, J.-C., Aerts, S., Imrichova, H., Atak, Z. K., Dewaele, M., Rambow, F., Hulselmans, G., Christiaens, V., Svetlichnyy, D., & Luciani, F. (2015). Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nature communications, 6, 6683. doi:10.1038/ncomms7683
  3. 63. El Hajj, P., Krayem, M., Fayyad Kazan, H., Badran, B., Ghanem, G. E., & Journé, F. (2015). Differential expression profiles of microRNAs involved in malignant melanocyte pigmentation. International Journal of Biological & Pharmaceutical Research, 6, 411-418.
  4. 64. Krayem, M., Journé, F., Wiedig, M., Morandini, R., Sales, F., Awada, A., & Ghanem, G. E. (2014). Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib. European journal of cancer. doi:10.1016/j.ejca.2014.01.021
  5. 65. Nielsen, T. O., Poulsen, S. S., Journé, F., Ghanem, G. E., & Sorensen, B. S. (2014). HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma. Melanoma research, 24(1), 88-91. doi:10.1097/CMR.0000000000000040
  6. 66. Aftimos, P., Wiedig, M., Langouo Fontsa, M., Awada, A., Ghanem, G. E., & Journé, F. (2013). Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profiles. International journal of oncology, 43(3), 919-926. doi:10.3892/ijo.2013.2008
  7. 67. Kindt, N., Laurent, G., Nonclercq, D., Journé, F., Ghanem, G. E., Duvillier, H., Gabius, H.-J., Lechien, J., & Saussez, S. (2013). Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. International journal of oncology, 43(1), 185-193. doi:10.3892/ijo.2013.1944
  8. 68. El Hajj, P., Journé, F., Wiedig, M., Laïos, I., Salès, F., Galibert, M.-D., Van Kempen, L. C., Spatz, A., Badran, B., Larsimont, D., Awada, A., & Ghanem, G. E. (2013). Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients. British Journal of Cancer, 108(8), 1641-1647. doi:10.1038/bjc.2013.115
  9. 69. Herraiz, C., Journé, F., Ghanem, G. E., Jimenez-Cervantes Frigo, C., & Garcia-Borron, J. C. (2012). Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells. International journal of biochemistry & cell biology, 44(12), 2244-2252. doi:10.1016/j.biocel.2012.09.008
  10. 70. Desmedt, C., Majjaj, S., Kheddoumi, N., Singhal, S. K., Haibe-Kains, B., El Ouriaghli, F., Chaboteaux, C., Michiels, S., Lallemand, F., Journé, F., Duvillier, H., Loi, S., Quackenbush, J., Dekoninck, S., Blanpain, C., Lagneaux, L., Houhou, N., Delorenzi, M., Larsimont, D., Piccart-Gebhart, M., & Sotiriou, C. (2012). Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment. Clinical cancer research, 18(4), 1004-1014. doi:10.1158/1078-0432.CCR-11-0383
  11. 71. Id Boufker, H., Lagneaux, L., Fayyad Kazan, H., Badran, B., Najar, M., Wiedig, M., Ghanem, G. E., Laurent, G., Body, J.-J., & Journé, F. (2011). Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts. Bone, 49(6), 1219-1231. doi:10.1016/j.bone.2011.08.013
  12. 72. Journé, F., Id Boufker, H., van Kempen, L., Galibert, M.-D., Wiedig, M., Sales, F., Theunis, A., Nonclercq, D., Frau, A., Laurent, G., Awada, A., & Ghanem, G. E. (2011). TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome. British Journal of Cancer, 105(11), 1726-1732. doi:10.1038/bjc.2011.451
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>